“Calcivis is a shining example of how Scotland is leading the way in developing cutting-edge technology that improves our health and wellbeing. We are proud to back the company’s pioneering work in dentistry and help its flagship product reach international markets, creating jobs in Scotland.
“As a development investment bank, we see Calcivis’ technology as fully aligned with our Innovation mission, and the product’s launch in the UK has the potential to deliver substantial health benefits to people in Scotland.”
“As a development investment bank, we see Calcivis’ technology as fully aligned with our Innovation mission, and the product’s launch in the UK has the potential to deliver substantial health benefits to people in Scotland.”
Key Information
Key Mission
Harnessing Innovation
Amount Invested
£4m
Location
Edinburgh
Co-Funders
£1m from IFS Maven Equity Finance, managed by Maven Capital Partners and part of the Investment Fund for Scotland (IFS), delivered by the British Business Bank
Alignment to the United Nation's Sustainable Development Goals
All of the investments the Bank makes support the UN's Sustainable Development Goals. This investment supports the goals below:
Image
Goal 3
Good Health and Well-being
Image
Goal 8
Decent Work and Economic Growth
Image
Goal 9
Industry, Innovation and Infrastructure
Key Quote
Adam Christie, CEO of Calcivis said: “Early diagnosis and treatment of tooth decay is essential, allowing patients to reverse the damage to their teeth before it is too late. This investment will enable us to launch our innovative product to global markets – first in the US and eventually in the UK – leading to faster diagnoses and early intervention treatments.
“This technology has the potential to revolutionise prevention in oral health care, with cavities impacting more than 2 billion people globally, according to the World Health Organisation. We look forward to seeing where this product can go with the support of the Bank and Maven.”
